PRTN3 and rheumatoid arthritis: To identify biomolecular or cellular differences between ACPA+ RA and ACPA− RA, investigators have used high-throughput molecular profiling approaches, such as metabolomics8, single-cell RNA-seq on peripheral blood mononuclear cells and synovial tissue9, flow cytometry immunophenotyping10, and gut microbiome sequencing11.